Back to Search
JENNIFER BRYAN DO
DO
Neuromusculoskeletal Medicine & OMM Physician
NPI: 1558090878IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neuromusculoskeletal Medicine & OMM PhysicianPrimary
Neuromusculoskeletal Medicine & OMM
Code: 204D00000X
DO.OP.70012965(WA)
Education
OTHER
Class of 2022
Research & Publications (20)
Cost considerations of malaria chemoprophylaxis including use of primaquine for primary or terminal chemoprophylaxis.
PMID 16968914·Am J Trop Med Hyg·2006
8-other
The influence of dopants on the nucleation of semiconductor nanocrystals from homogeneous solution.
PMID 16193960·J Nanosci Nanotechnol·2005
8-other
Activation of high-TC ferromagnetism in Co2+:TiO2 and Cr3+:TiO2 nanorods and nanocrystals by grain boundary defects.
PMID 16262422·J Am Chem Soc·2005
8-other
Strong room-temperature ferromagnetism in Co2+-doped TiO2 made from colloidal nanocrystals.
PMID 15366911·J Am Chem Soc·2004
8-other
Streptococcus agalactiae CspA is a serine protease that inactivates chemokines.
PMID 19114481·J Bacteriol·2009
8-other
Comparison of systemic toxicities of 177Lu-DOTMP and 153Sm-EDTMP administered intravenously at equivalent skeletal doses to normal dogs.
PMID 19223431·J Nucl Med Technol·2009
4-observational
Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine.
PMID 19647066·Vaccine·2009
2-rct
Human papillomavirus 6 seropositivity is associated with risk of head and neck squamous cell carcinoma, independent of tobacco and alcohol use.
PMID 19087986·Ann Oncol·2009
8-other
Incomplete dissociation of glibenclamide from wild-type and mutant pancreatic K ATP channels limits their recovery from inhibition.
PMID 19154434·Br J Pharmacol·2009
7-preclinical
Presumptive increase in protein-bound serum calcium in a dog with multiple myeloma.
PMID 19171018·Vet Clin Pathol·2009
5-case
The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24.
PMID 19453788·J Eur Acad Dermatol Venereol·2009
8-other
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
PMID 19493565·Lancet·2009
3-trial
Association between dietary saccharide intake and self-reported memory performance in middle-aged adults.
PMID 18466658·Br J Nutr·2009
8-other
Activation of the Na+/K+-ATPase by insulin and glucose as a putative negative feedback mechanism in pancreatic beta-cells.
PMID 18836740·Pflugers Arch·2009
7-preclinical
Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer.
PMID 19346260·Carcinogenesis·2009
8-other
Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.
PMID 19139106·J Biol Chem·2009
8-other
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.
PMID 19236277·J Infect Dis·2009
3-trial
The CiaR response regulator in group B Streptococcus promotes intracellular survival and resistance to innate immune defenses.
PMID 19114476·J Bacteriol·2009
7-preclinical
Study comparing human papillomavirus (HPV) real-time multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV genotyping PCR assays.
PMID 19420164·J Clin Microbiol·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 100 E JACKSON AVE
ELLENSBURG, WA 98926 - Phone
- (509) 933-8777
Quick Facts
- NPI
- 1558090878
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile